Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Tuberculosis

Free Subscription 19.05.2025 2 Clin Infect Dis 1 Eur J Clin Microbiol Infect Dis 1 J Clin Microbiol 3 PLoS One 1 Proc Natl Acad Sci U S A 1 Respir Med 1 Trop Med Int Health

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Clin Infect Dis

1. REGAN JJ, Wang Z, Phares CR
   The Effect of Live-Virus Vaccines on Tests for Tuberculosis Infection During the US Immigration Medical Examination: Are Vaccines Causing False-Negative Results?
   Clin Infect Dis. 2025 May 15:ciaf129. doi: 10.1093.
   PubMed         Abstract available
   
   
2. STADLER JAM, Kuhlin JJ, Molloy SF, Mtwa NN, et al
   Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
   Clin Infect Dis. 2025 May 9:ciaf112. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Eur J Clin Microbiol Infect Dis

3. FEI ZT, Zhou DP, Huang W, Liu P, et al
   Clinical characteristics and outcomes of tuberculosis and non-tuberculous mycobacteria infections: a population-based study of concurrent and sequential infections.
   Eur J Clin Microbiol Infect Dis. 2025 May 9. doi: 10.1007/s10096-025-05151.
   PubMed         Abstract available
   
   

   
   J Clin Microbiol

4. SERGE DIAGBOUGA P, Djibougou AD, Pease C, Alcaide A, et al
   Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with Mycobacterium tuberculosis.
   J Clin Microbiol. 2025 May 14:e0164124. doi: 10.1128/jcm.01641.
   PubMed         Abstract available
   
   

   
   PLoS One

5. SHIN E, Yun JS, Lee YR, Cha HR, et al
   Efficacy and immunogenicity of rKVAC85B in a BCG prime-boost regimen against H37Rv and HN878 Mycobacterium tuberculosis strains.
   PLoS One. 2025;20:e0322147.
   PubMed         Abstract available
   
   
6. BEYENE RA, Janse van Rensburg E
   Prevention and control of multidrug-resistance tuberculosis in Ethiopia: Patients' perspectives from the Oromia region.
   PLoS One. 2025;20:e0322054.
   PubMed         Abstract available
   
   
7. NTSHIQA T, Velen K, Ginindza S, Nhlangulela L, et al
   Resistance to tuberculin skin test/interferon-gamma release assay conversion among highly TB exposed, HIV infected goldminers in South Africa.
   PLoS One. 2025;20:e0318819.
   PubMed         Abstract available
   
   

   
   Proc Natl Acad Sci U S A

8. SANTAMARIA C, Biegas KJ, Lim PN, Cabral J, et al
   Trehalose dimycolate inhibits phagosome maturation and promotes intracellular M. tuberculosis growth via noncanonical SNARE interactions.
   Proc Natl Acad Sci U S A. 2025;122:e2423292122.
   PubMed         Abstract available
   
   

   
   Respir Med

9. GAO W, Yang C, Wang T, Guo Y, et al
   Clinical predictive model for identifying high-risk factors in pleurisy tuberculoma patients.
   Respir Med. 2025;242:108039.
   PubMed         Abstract available
   
   

   
   Trop Med Int Health

10. HAN N, Yan L, Yuan M, Chen Z, et al
    Characteristics and risk factors of drug-resistant tuberculosis in Sichuan, China: An observational study.
    Trop Med Int Health. 2025 May 15. doi: 10.1111/tmi.14126.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.